EPISODE · Aug 27, 2026 · 25 MIN
How NVIDIA Turns Computing Into A New Lab Partner
from What's Up with Tech? · host Evan Kirstel
Interested in being a guest? Email us at [email protected] discovery is one of the hardest engineering problems on Earth, except it has not always been treated like engineering. Costs can hover around $2 billion per successful drug, timelines can run 10+ years, and too many patients still wait without a cure. We sit down with Rory Kelleher, who leads global business development for life sciences at NVIDIA, to talk about what changes when accelerated computing meets foundation models, generative AI, and agentic AI that can actually do work.We break down how scientific agents differ from chatbots, and why tools matter as much as models. Rory explains NVIDIA’s BioNEMO Agent Toolkit and the idea of turning core life sciences capabilities into “agent skills” so biologists and chemists can run complex workflows through natural language. We talk protein design and protein binder design, co-folding, bioinformatics, target identification, and ADMET prediction for toxicity and safety, plus why this wave can “democratize” computational drug discovery for scientists who were never trained as programmers.You’ll also hear a real example from Bristol Myers Squibb, where foundation models trained on proprietary sequences and compound libraries helped improve a sickle cell molecule profile until it reached first-in-human testing. We dig into what an “AI factory” looks like inside pharma, why teams want to run open models and local LLMs on secure infrastructure, and why scientific judgment becomes more important, not less, as agents increase throughput.If you care about biotech, pharma R&D, life sciences AI, and the future of medicine, this conversation is for you. Subscribe, share the episode with a friend in research, and leave a review with the one workflow you want agents to tackle next.Everyday AI: Your daily guide to grown with Generative AICan't keep up with AI? We've got you. Everyday AI helps you keep up and get ahead.Listen on: Apple Podcasts SpotifySupport the showMore at https://linktr.ee/EvanKirstel
Embed this episode
What this episode covers
Interested in being a guest? Email us at [email protected] Drug discovery is one of the hardest engineering problems on Earth, except it has not always been treated like engineering. Costs can hover around $2 billion per successful drug, timelines can run 10+ years, and too many patients still wait without a cure. We sit down with Rory Kelleher, who leads global business development for life sciences at NVIDIA, to talk about what changes when accelerated computing meets foundation models,...
NOW PLAYING
How NVIDIA Turns Computing Into A New Lab Partner
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.